Respiratory Medicine

Degradation of lipid based drug delivery formulations during nebulization
David M. Klein, Albert Poortinga, Frank M. Verhoeven, Daniel Bonn, Sylvestre Bonnet, Cees J.M. van Rijn

medRxiv 2021.03.16.21253714; doi: https://doi.org/10.1101/2021.03.16.21253714

Add to Selected Citations
High incidence of pulmonary thromboembolism in hospitalized SARS-CoV-2 infected patients
D El-Qutob, L Alvarez, P García-Sidro, M Robustillo, I Barreda, M Nieto, M Pin, FJ Carrera-Hueso

medRxiv 2021.03.23.21253258; doi: https://doi.org/10.1101/2021.03.23.21253258

Add to Selected Citations
Validation of breath biomarkers for obstructive sleep apnea
Nora Nowak, Anna Engler, Sira Thiel, Anna S. Stöberl, Pablo Sinues, Renato Zenobi, Malcolm Kohler

medRxiv 2021.03.16.21253612; doi: https://doi.org/10.1101/2021.03.16.21253612

Add to Selected Citations
Evaluation of the ROX index in SARS-CoV-2 Acute Respiratory failure treated with both High-Flow Nasal Oxygen (HFNO) and Continuous Positive Airway Pressure (CPAP)
Hakim Ghani, Michael Shaw, Phyoe Pyae, Rigers Cama, Meghna Prabhakar, Alessio Navarra, Rahul Mogal, Andrew Barlow, Nazril Nordin, Rama Vancheeswaran, Janice Yu Ji Lee, Felix Chua

medRxiv 2021.03.23.21254203; doi: https://doi.org/10.1101/2021.03.23.21254203

Add to Selected Citations
Pulmonary Fibrosis after COVID-19 is Associated with Severity of Illness and Blood Leukocyte Telomere Length
Claire F. McGroder, David Zhang, Mohammad A. Choudhury, Mary M. Salvatore, Belinda M. D’Souza, Eric A. Hoffman, Ying Wei, Matthew R. Baldwin, Christine Kim Garcia

medRxiv 2021.03.17.21253834; doi: https://doi.org/10.1101/2021.03.17.21253834

Add to Selected Citations
Post-viral parenchymal lung disease of COVID-19 and viral pneumonitis: A systematic review and meta-analysis
Laura Fabbri, Samuel Moss, Fasihul Khan, Wenjie Chi, Jun Xia, Karen Robinson, Alan Smyth, Gisli Jenkins, Iain Stewart

medRxiv 2021.03.15.21253593; doi: https://doi.org/10.1101/2021.03.15.21253593

Add to Selected Citations
Viral Pneumonia is Associated with Increased Risk and Earlier Development of Post-Inflammatory Pulmonary Fibrosis
Abbas Shojaee, Jonathan M. Siner, Andrey Zinchuk, Yalda Aryan, Naftali Kaminski, Charles S. Dela Cruz

medRxiv 2021.03.08.21252412; doi: https://doi.org/10.1101/2021.03.08.21252412

Add to Selected Citations
A phase 2 study of the inhaled pan-JAK inhibitor TD-0903 in severe COVID-19: Part 1
Dave Singh, Maxim Bogus, Valentyn Moskalenko, Robert Lord, Edmund J. Moran, Glenn D. Crater, David L. Bourdet, Nathan D. Pfeifer, Jacky Woo, Elad Kaufman, David A. Lombardi, Emily Y. Weng, Tuan Nguyen, Ashley Woodcock, Brett Haumann, Rajeev Saggar

medRxiv 2021.03.09.21252944; doi: https://doi.org/10.1101/2021.03.09.21252944

Add to Selected Citations
Effectiveness of a telerehabilitation program for COVID-19 survivors (TERECO) on exercise capacity, pulmonary function, lower limb muscle strength, and quality of life: a randomized controlled trial
Jian’an Li, Wenguang Xia, Chao Zhan, Shouguo Liu, Zhifei Yin, Jiayue Wang, Yufei Chong, Chanjuan Zheng, Xiaoming Fang, Wei Cheng, Jan D. Reinhardt

medRxiv 2021.03.08.21253007; doi: https://doi.org/10.1101/2021.03.08.21253007

Add to Selected Citations
Patients with Asthma and Chronic Obstructive Pulmonary Disease (COPD) have increased levels of plasma inflammatory mediators upregulated in severe COVID-19
Nathalie Acevedo, Jose Miguel Escamilla-Gil, Héctor Espinoza, Ronald Regino, Jonathan Ramírez, Lucila Florez de Arco, Rodolfo Dennis, Carlos Torres-Duque, Luis Caraballo

medRxiv 2021.01.23.21250370; doi: https://doi.org/10.1101/2021.01.23.21250370

Add to Selected Citations

Respiratory Medicine

Pages